Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Ed Schutter, President and Chief Operating Officer, will make a presentation at the UBS Global Specialty and Generic Pharmaceuticals Conference at the Waldorf Hilton Hotel in London on Thursday, May 29, 2008, at 11:00 a.m. local time (6:00 a.m. Eastern time).

The audio presentation is being broadcast on the Internet and may be accessed at the Company’s website, www.sciele.com.

Sciele Pharma, Inc. Background

Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular, Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular and Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and attention deficit and hyperactivity disorder (ADHD). Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 900 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform – an Entrepreneurial Spirit, Innovation, Execution Excellence, Simplicity, and Teamwork.

Sciele Pharma, Inc.
Joseph T. Schepers
Director of Investor Relations
678-341-1401
ir@sciele.com